Abstract | PURPOSE: METHODS: RESULTS: After recombinant human FSH therapy, we did not find any differences in terms of sperm count, motility and morphology. The average DNA fragmentation index was significantly reduced (21.15 vs 15.2, p<0.05), but we found a significant reduction in patients with high basal DFI values (>15 %), while no significant variation occurred in the patients with DFI values ≤ 15 %. CONCLUSIONS:
|
Authors | Giovanni Ruvolo, Maria Carmela Roccheri, Anna Maria Brucculeri, Salvatore Longobardi, Ettore Cittadini, Liana Bosco |
Journal | Journal of assisted reproduction and genetics
(J Assist Reprod Genet)
Vol. 30
Issue 4
Pg. 497-503
(Apr 2013)
ISSN: 1573-7330 [Electronic] Netherlands |
PMID | 23435529
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Follicle Stimulating Hormone, Human
- Recombinant Proteins
|
Topics |
- Adult
- Asthenozoospermia
(genetics, metabolism)
- DNA Fragmentation
- Follicle Stimulating Hormone, Human
(administration & dosage)
- Humans
- Hypogonadism
(genetics, metabolism)
- Male
- Oligospermia
(genetics, metabolism)
- Recombinant Proteins
(administration & dosage)
- Sperm Count
- Spermatozoa
(cytology, metabolism)
|